<prompt> Vorapaxar acts by inhibitingGPIIa IIIbP2Y12 receptorPAR - 1Antithrombin - 3  <response>: Vorapaxar inhibits Protease Activated Receptor 1 PAR1 which is a thrombin receptor and thus can be used as a antiplatelet drug in M.I 